We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Warders Medical Centre
Access to tirzepatide (Mounjaro) through primary care
Although it has been announced that Tirzepatide (Mounjaro®) will become available in primary care settings from Monday, 23 June (for a specific patient cohort).
Currently, the support service required in the NICE guidelines is not yet available in Kent and Medway, so GP practices are not able to prescribe Tirzepatide (Mounjaro) at this time.
Please note there is no provider of tirzepatide (Mounjaro) available under right to choose.
NICE guidelines say that in order to gain access to tirzepatide (Mounjaro) on the NHS, patients must also be referred on to a diet and exercise support programme. Arrangements are being made to mobilise a provider of the necessary Behavioural support for Obesity Prescribing (BSOP) that is specified in the NICE guidelines. Until this service is in place in Kent and Medway, it is not possible to prescribe tirzepatide (Mounjaro) in primary care.
You can find more information on the Kent and Medway ICS website
Published: Jun 24, 2025